SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 193 filers reported holding SAGE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $329,710 | -8.1% | 30,360 | +58.6% | 0.01% | 0.0% |
| Q1 2024 | $358,759 | -8.8% | 19,144 | +5.5% | 0.01% | -12.5% |
| Q4 2023 | $393,181 | -50.6% | 18,144 | +7.3% | 0.01% | -50.0% |
| Q2 2023 | $795,297 | +12.1% | 16,914 | 0.0% | 0.02% | +14.3% |
| Q1 2023 | $709,712 | – | 16,914 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 190,000 | $13,716,100 | 11.97% |
| GREAT POINT PARTNERS LLC | 796,057 | $57,467,000 | 5.00% |
| Logos Global Management LP | 190,150 | $13,727,000 | 3.38% |
| Integral Health Asset Management, LLC | 120,000 | $8,663,000 | 3.37% |
| DAFNA Capital Management LLC | 124,806 | $9,010,000 | 3.09% |
| Palo Alto Investors LP | 653,594 | $47,183,000 | 2.60% |
| Ghost Tree Capital, LLC | 150,000 | $10,829,000 | 2.06% |
| Eventide Asset Management | 790,000 | $57,030,000 | 1.61% |
| Ikarian Capital, LLC | 133,000 | $9,601,000 | 1.56% |
| Casdin Capital, LLC | 230,000 | $16,604,000 | 1.53% |